Market Cap
Bristol-Myers Squibb Company
$170.56 Billion
USD as of April 1, 2022
Company | Market Cap (USD) |
---|---|
![]() |
$475.93 B |
![]() |
$349.50 B |
![]() |
$300.79 B |
![]() |
$294.27 B |
![]() |
$273.01 B |
Company | Market Cap (USD) |
---|---|
![]() |
$488.52 B |
![]() |
$475.93 B |
![]() |
$349.50 B |
![]() |
$300.79 B |
![]() |
$294.27 B |
Bristol Myers Squibb Company, also known as BMS, is a multinational pharmaceutical company. Tracing its origins to1858, it develops and manufactures prescription pharmaceuticals and biologics for a diverse range of diseases including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.